ETFs
R
RPRX
Royalty Pharma Plc
54.01
-1.17-2.12%After Hours: 54.01 0.00 0.00%16:10 06/02 EDT
OPEN/PREV CLOSE54.18/54.01
TODAY RANGE53.95-55.51
VOL4.47M
MARKET CAP31.65B
52 WEEK RANGE31.96-56.07
AVG VOL (3M)3.58M
% TURNOVER0.78%
TURNOVER--
P/E (TTM)28.80
% RANGE2.84%
EPS(TTM)1.909
P/E(FORWARD)17.79
P/B4.598
BVPS11.96
DIVIDEND0.9400
P/S13.34
BETA--
DIV YIELD1.71%
FREE FLOAT MKT CAP22.62B
SHARES OUTSTANDING575.83M
NEXT EARNINGS08/04-08/10
FREE FLOAT411.47M
LOT SIZE1
EX-DATE05/15/2026
News
Press Releases
Financial Reports
Profile
TipRanks·6d ago
Royalty Pharma Secures New $1.8 Billion Credit Facility
Simply Wall St·6d ago
How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships
TipRanks·05/26 10:50
Analysts’ Top Healthcare Picks: Amneal Pharmaceuticals (AMRX), Immunovant (IMVT)
Seeking Alpha·05/16 07:12
Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead
Simply Wall St·05/14 12:34
Royalty Pharma (RPRX) Valuation Check After Strong Q1 Earnings And Rising Investor Interest
Simply Wall St·05/10 16:21
Accelerated Royalty Deals and Dividend Hike Could Be A Game Changer For Royalty Pharma (RPRX)
Dow Jones·05/07 21:04
Royalty Pharma Price Target Raised to $66.00/Share From $50.00 by Citigroup
Same Industry
Name/Symbol
Change%
Price